154919-93-4

Basic information

• Product Name: (S)-4-Benzyl-3-[(2S,3R)-6-(tert-butyl-dimethyl-silanyloxy)-3-hydroxy-2-methyl-hexanoyl]-oxazolidin-2-one
• Synonyms: (S)-4-Benzyl-3-[(2S,3R)-6-(tert-butyl-dimethyl-silanyloxy)-3-hydroxy-2-methyl-hexanoyl]-oxazolidin-2-one
• CAS NO: 154919-93-4
• Molecular Weight: 435.636
• Mol File: 154919-93-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (S)-4-Benzyl-3-[(2S,3R)-6-(tert-butyl-dimethyl-silanyloxy)-3-hydroxy-2-methyl-hexanoyl]-oxazolidin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-4-Benzyl-3-[(2S,3R)-6-(tert-butyl-dimethyl-silanyloxy)-3-hydroxy-2-methyl-hexanoyl]-oxazolidin-2-one(154919-93-4)
• EPA Substance Registry System: (S)-4-Benzyl-3-[(2S,3R)-6-(tert-butyl-dimethyl-silanyloxy)-3-hydroxy-2-methyl-hexanoyl]-oxazolidin-2-one(154919-93-4)

Safety Data

• Hazardous Substances Data: 154919-93-4(Hazardous Substances Data)

Upstream product

• 18162-48-6 tert-butyldimethylsilyl chloride 
• 87184-81-4 4-(tert-butyldimethylsilanyloxy)butanal 
• 131685-53-5 (S)-4-benzyl-3-propionyl-2-oxazolidinone 

Downstream Products

• 565228-73-1 (1S,2S,3R,6Z,8S,9S,10S,11Z)-[3,9-bis(4-methoxybenzyloxy)-14-[(2S,3S,4S,5R,6R)-6-methoxy-4-methoxymethoxy-3,5-dimethyltetrahydropyran-2-yl]-2,8,10-trimethyl-1-[(1S,2Z)-1-methylpenta-2,4-dienyl]tetradeca-6,11-dienyloxy]-tert-butyldimethylsilane 
• 565229-72-3 carbamic acid, (1S,2S,3R,6Z,8S,9S,10S,11Z)-3,9-bis(4-methoxybenzyloxy)-14-[(2S,3S,4S,5R,6R)-6-methoxy-4-methoxymethoxy-3,5-dimethyltetrahydropyran-2-yl]-2,8,10-trimethyl-1-[(1S,2Z)-1-methylpenta-2,4-dienyl]tetradeca-6,11-dienyl ester 
• 565228-57-1 carbamic acid, (1S,2S,3R,6Z,8S,9S,10S,11Z)-3,9-bis(4-methoxybenzyloxy)-14-[(2S,3S,4S,5R)-4-methoxymethoxy-3,5-dimethyl-6-oxotetrahydropyran-2-yl]-2,8,10-trimethyl-1-[(1S,2Z)-1-methylpenta-2,4-dienyl]tetradeca-6,11-dienyl ester 
• 565229-82-5 Carbamic acid (6Z,11Z)-(1S,2S,3R,8S,9R,10S)-14-((2S,3S,4S,5R)-4-hydroxy-3,5-dimethyl-6-oxo-tetrahydro-pyran-2-yl)-3,9-bis-(4-methoxy-benzyloxy)-2,8,10-trimethyl-1-((Z)-(S)-1-methyl-penta-2,4-dienyl)-tetradeca-6,11-dienyl ester 
• 565229-96-1 Carbamic acid (6Z,11Z)-(1S,2S,3R,8S,9R,10S)-1-isopropyl-3,9-bis-(4-methoxy-benzyloxy)-14-((2S,3R,4S,5R)-4-methoxymethoxy-3,5-dimethyl-6-oxo-tetrahydro-pyran-2-yl)-2,8,10-trimethyl-tetradeca-6,11-dienyl ester 
• 565229-57-4 carbamic acid, (1S,2S,3R,6Z,8S,9S,10S,11Z)-1-isopropyl-3,9-bis(4-methoxybenzyloxy)-14-[(2R,3R,4S,5R,6R)-6-methoxy-4-methoxymethoxy-3,5-dimethyltetrahydropyran-2-yl]-2,8,10-trimethyltetradeca-6,11-dienyl ester 
• 565229-55-2 carbamic acid, (1S,2S,3R,6Z,8S,9S,10S,11Z)-1-isopropyl-3,9-bis(4-methoxybenzyloxy)-14-[(2R,3S,4S,5R,6R)-6-methoxy-4-methoxymethoxy-3,5-dimethyltetrahydropyran-2-yl]-2,8,10-trimethyltetradeca-6,11-dienyl ester 
• 565229-93-8 (8Z,13Z)-(3S,4R,5R,10S,11R,12S)-5,11-Bis-(4-methoxy-benzyloxy)-16-((2S,3S,4S,5R,6R)-6-methoxy-4-methoxymethoxy-3,5-dimethyl-tetrahydro-pyran-2-yl)-2,4,10,12-tetramethyl-hexadeca-8,13-dien-3-ol 
• 565229-92-7 (1S,2S,3R,6Z,8S,9S,10S,11Z)-5,11-bis(4-methoxybenzyloxy)-16-[(2R,3S,4S,5R,6R)-6-methoxy-4-methoxymethoxy-3,5-dimethyltetrahydropyran-2-yl]-2,4,10,12-tetramethylhexadeca-8,13-dien-3-ol 
• 565229-91-6 (6Z,11Z)-(2R,3R,8S,9R,10S)-3,9-Bis-(4-methoxy-benzyloxy)-14-((2S,3S,4S,5R,6R)-6-methoxy-4-methoxymethoxy-3,5-dimethyl-tetrahydro-pyran-2-yl)-2,8,10-trimethyl-tetradeca-6,11-dien-1-ol 

Relevant articles and documents

Simplified discodermolide analogues: Synthesis and biological evaluation of 4-epi-7-dehydroxy-14,16-didemethyl-(+)-discodermolides as microtubule-stabilizing agents

Several novel analogues of (+)-discodermolide were synthesized via a convergent strategy that used Wittig reactions to append left and right side chains to a central scaffold and then tested for biological activity. Three of the analogues in the 4-epi-7-d

The asymmetric syntheses of the C-1 sidechains of zaragozic acid A and zaragozic acid C

The asymmetric syntheses of the C-1 sidechains of zaragozic acid A and C are described. Aldol reaction defines the chirality at C-4' and C-5' in two independent routes. Multigram preparation as well as a route amenable to derivatization are highlights of